- Potential benefitPrevents implementation of prior authorization requirements that would have added administrative burden to clinicians a…
- Potential benefitReduces potential for delayed patient access to certain Medicare-covered services due to prior authorization processes.
- Potential benefitAvoids compliance costs for providers and insurers tied to new authorization systems and IT integration.
Disapprove CMS WISeR Prior Authorization Rule
Placed on Senate Legislative Calendar under General Orders. Calendar No. 447.
This resolution uses the Congressional Review Act to nullify a federal agency rule. If Congress approves the resolution and the President signs it (or a veto is overridden), the named rule is treated as having no force or effect. The Act also prevents the agency from issuing a substantially similar rule in the future unless Congress passes new law authorizing it.
The rule titled "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model."
Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS)
Under the Congressional Review Act, this disapproval resolution is subject to expedited procedures in the Senate that limit debate and prevent a filibuster, so it can pass there with a simple majority; it must also pass the House and be presented to the President to take effect.
This joint resolution under the Congressional Review Act would disapprove and nullify a Centers for Medicare & Medicaid Services rule titled “Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model,” removing that rule from effect.
Narrow regulatory target raises feasibility in one chamber, but needing approval in both and possible executive opposition, plus stakeholder lobbying, reduce overall odds.
Relative to its intended legislative type, this bill is a narrowly targeted Congressional Review Act disapproval that is clear about its legal effect and integrates explicitly with the CRA framework, but it provides minimal ancillary detail (fiscal, transitional, or oversight) beyond what the governing statute supplies.
Progressives emphasize protecting patient access and avoiding delays
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenBlocks CMS efforts to curb wasteful or inappropriate services through utilization management.
- Potential burdenMay maintain higher Medicare program spending that the prior authorization rule intended to reduce.
- Potential burdenKeeps status quo that could allow continued provision of low-value or unnecessary services.
Why the argument around this bill splits.
Progressives emphasize protecting patient access and avoiding delays
Likely supportive of disapproval because prior authorization can delay care and add administrative burdens.
Support would be tempered by interest in reducing waste and ensuring Medicare integrity.
Mixed view: appreciates goals to curb waste but worries about access harms from blunt prior-authorization rules.
Prefers fixing or phasing implementation rather than outright nullification.
Generally supportive of disapproval as a check on administrative overreach and regulatory burden.
Views CRA use as appropriate to block an intrusive federal prior-authorization regime.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow regulatory target raises feasibility in one chamber, but needing approval in both and possible executive opposition, plus stakeholder lobbying, reduce overall odds.
- Absent official cost or budgetary estimate
- Unknown positions of major provider and beneficiary groups
Recent votes on the bill.
The Senate declined to take up this bill. It cannot be debated or voted on unless the motion is tried again.
Go deeper than the headline read.
Progressives emphasize protecting patient access and avoiding delays
Narrow regulatory target raises feasibility in one chamber, but needing approval in both and possible executive opposition, plus stakeholde…
Relative to its intended legislative type, this bill is a narrowly targeted Congressional Review Act disapproval that is clear about its legal effect and integrates explicitly with the CRA framework, but it provides min…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.